This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This case report describes an atypical presentation of CAS in a 68-year-old white British male with cardiovascular riskfactors. This case emphasises the importance of recognising plaque-associated CAS as a potential trigger for life-threatening arrhythmias, even in the absence of chest pain.
tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S.
Stroke, Volume 56, Issue Suppl_1 , Page AWP338-AWP338, February 1, 2025. Advancements in magnetic resonance angiography (MRA) with vessel wall imaging (VWI) have enabled the identification of vulnerable plaques, aiding in risk stratification for neurovascular events. Eleven plaques were vulnerable in preoperative MRI with VWI.
Circulation, Volume 151, Issue 6 , Page 400-415, February 11, 2025. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent riskfactor for astherosclerotic cardiovascular disease, with proinflammatory and prothrombotic mechanisms contributing to its atherogenicity.
Stroke, Volume 56, Issue Suppl_1 , Page ATP205-ATP205, February 1, 2025. Introduction:Alzheimers Disease (AD), characterized by extracellular deposition of amyloid beta (A) plaques in brain tissue, is often comorbid with cerebral amyloid angiopathy, which carries an elevated risk of intracranial hemorrhage.
Stroke, Volume 56, Issue Suppl_1 , Page ATP258-ATP258, February 1, 2025. Stroke riskfactors and CT angiography (CTA) of the head and neck features were compared between LAA and non-LAA etiologies in a univariate analysis. p<0.0001), and ICA bulb plaque with high-risk features (87.9%
tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has released clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg on atherosclerotic plaque.
Blood Pressure High blood pressure is the riskfactor responsible for the greatest number of deaths worldwide 2. For every 20mmHg increase in systolic (Top Number) blood pressure, the risk of dying from a heart attack or stroke doubles 3. It is an even better time to start putting in the work towards reducing that risk.
tim.hodson Tue, 02/04/2025 - 17:13 Feb. 3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. Patients should know the riskfactors for PAD so that they dont dismiss symptoms as just getting older, saidRobert J.
tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.
Stroke, Volume 56, Issue Suppl_1 , Page ATP358-ATP358, February 1, 2025. Introduction:Stroke is a well-established independent riskfactor for the development of dementia. Most dementia patients exhibit mixed brain pathologies, with histological evidence of ischemia and A plaque accumulation, observed at autopsy.
Provocative testing is very helpful for this Coronary Thrombus with lysis (one must do optical coherence tomography or at least intravascular ultrasound to find thes non-obstructive plaques that ruptured. I suspect this statement is still true 2 years later, in 2025. Embolism with lysis. Need to find an embolic source.
Still, an ECG was obtained at 0649hrs: (Digitized by PM Cardio) McLaren: The patient has a high pretest probability based on age, riskfactors and symptoms. Influenza-like illness can also trigger plaque rupture. Beware confusing the diagnosis of posterior STEMI by using posterior leads.
42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant riskfactors. In the U.S.,
tim.hodson Thu, 01/23/2025 - 10:53 Jan. 22, 2025 -- HeartFlow, Inc. , While up to one in three retired professional football players die of cardiovascular disease, much remains unknown about the prevalence of riskfactors and severity of disease among these former high-performing athletes, said Jeffrey L. Boone, M.D.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content